Patenting Antibody and Cell Therapies – What to Do and What Not to Do

In Webinars

28 September, 2020

Click here to watch webinar.

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.

 

 

You may also be interested in:

The Business of IP – Understanding and Creating Value: Part 4 – Spin Offs

In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or

Read more...

Was this the last hurdle for German UPCA Ratification?

At the end of 2020, German ratification of the Agreement on a Unified Patent Court (UPCA) looked promising as

Read more...

Attracting Capital – Guiding the Growth Journey

In a series of programs initiated by AWA Denmark, the focus will be on what potential growth entrepreneurs should

Read more...

Mobile Sliding Menu